Laufbahn
2018–now | Specialist for Medical Oncology (Div. of Oncology, MUW) |
2016–2018 | Specialty training in Medical Oncology/Hematology at the (chief resident at the Div. of Hematology, Div. of Bone Marrow transplantation, Div. of Palliative Care) |
2016 | Specialization for Internal Medicine (Dep. of Medicine I, MUW) |
2013 | Diploma in emergency medicine |
2012 | PhD Degree in the Molecular Signaling thematic program |
2010–2016 | Resident at Div, of Oncology Dep. Of Medicine I, Medical University of Vienna |
2007–2010 | PhD in the Molecular Signaling thematic program, Dep. of Pharmacology Medical University of Vienna. Topic: Statin induced apoptosis in human melanoma cells Basic research: molecular biology and apoptosis signaling |
Auszeichungen
2020 | Medical Scientific Fund of the Mayor of the City of Vienna Title: "Predictive marker for thyroid dysfunction and outcome in patients receiving standard of care anti-PD-1/PD-L1 therapy: An explorative prospective biomarker study" |
2016–2018 | Jubiläumsfonds der Österreichischen Nationalbank Title: "Establishing a stable cell line from leptomeningeal carcinosis of breast cancer patients" |
2014 | Young Scientist Award Roche Title: "Impact of statins for the treatment of non-small cell lung cancer" |
2013–2019 | Medical Scientific Fund of the Mayor of the City of Vienna Title: "Impact of statins for the treatment of non-small cell lung cancer" |
Funktionen/Mitgliedschaften
ASCO, ESMO, ÖGIM, ÖGAHM, ÖAV